New Amsterdam Sciences
Pre-clinicalNew Amsterdam Sciences develops novel, safe and effective therapies for persistent inflammatory conditions specifically oxidative stress (ROS) driven inflammation, with an initial focus on Rheumatoid Arthritis, Infectious Disease and CNS disorders
Founded
2018
Focus
Small Molecules
About
New Amsterdam Sciences develops novel, safe and effective therapies for persistent inflammatory conditions specifically oxidative stress (ROS) driven inflammation, with an initial focus on Rheumatoid Arthritis, Infectious Disease and CNS disorders
Funding History
1SeedUndisclosedUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2018
LocationNew York, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile